FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
-8.4%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$22.8B
AUM Growth
-$4.41B
(-16%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
36.84%
Holding
614
New
135
Increased
158
Reduced
239
Closed
65
Top Buys
| 1 |
NVIDIA
NVDA
|
$198M |
| 2 |
Netflix
NFLX
|
$190M |
| 3 |
Lowe's Companies
LOW
|
$147M |
| 4 |
Starbucks
SBUX
|
$92.4M |
| 5 |
Novartis
NVS
|
$85.4M |
Top Sells
| 1 |
Abbott
ABT
|
$246M |
| 2 |
Microsoft
MSFT
|
$199M |
| 3 |
Dollar Tree
DLTR
|
$152M |
| 4 |
Salesforce
CRM
|
$144M |
| 5 |
Adobe
ADBE
|
$140M |
Sector Composition
| 1 | Technology | 33.16% |
| 2 | Healthcare | 22.78% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Communication Services | 9.78% |
| 5 | Financials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Wells Fargo
WFC
$253B
| $903K | ﹤0.01% |
31,474
-726
| -2% | -$20.8K |
|
|
XLRN
327
DELISTED
Acceleron Pharma Inc.
XLRN
| $899K | ﹤0.01% |
+10,000
| New | +$899K |
|
328
Chevron
CVX
$310B
| $895K | ﹤0.01% |
12,356
-307
| -2% | -$22.2K |
|
329
Zoom
ZM
$25B
| $888K | ﹤0.01% |
+6,077
| New | +$888K |
|
330
General Dynamics
GD
$86.8B
| $832K | ﹤0.01% |
6,290
-144
| -2% | -$19K |
|
331
Lamar Advertising Co
LAMR
$13B
| $823K | ﹤0.01% |
16,046
-374
| -2% | -$19.2K |
|
332
Aurinia Pharmaceuticals
AUPH
$1.63B
| $813K | ﹤0.01% |
56,000
+9,000
| +19% | +$131K |
|
333
ConocoPhillips
COP
$116B
| $805K | ﹤0.01% |
26,121
-606
| -2% | -$18.7K |
|
334
Philip Morris
PM
$251B
| $776K | ﹤0.01% |
+10,631
| New | +$776K |
|
335
Afya
AFYA
$1.37B
| $758K | ﹤0.01% |
39,753
+3,000
| +8% | +$57.2K |
|
336
Twist Bioscience
TWST
$1.55B
| $734K | ﹤0.01% |
+24,000
| New | +$734K |
|
337
OraSure Technologies
OSUR
$236M
| $726K | ﹤0.01% |
+67,449
| New | +$726K |
|
338
Blackstone Mortgage Trust
BXMT
$3.45B
| $723K | ﹤0.01% |
38,803
-895
| -2% | -$16.7K |
|
339
Cheniere Energy
CQP
$26.1B
| $713K | ﹤0.01% |
26,416
-612
| -2% | -$16.5K |
|
340
Zymeworks
ZYME
$1.14B
| $709K | ﹤0.01% |
20,000
-2,000
| -9% | -$70.9K |
|
341
STAG Industrial
STAG
$6.9B
| $708K | ﹤0.01% |
+31,442
| New | +$708K |
|
|
MRTX
342
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $692K | ﹤0.01% |
9,000
-3,500
| -28% | -$269K |
|
343
Iovance Biotherapeutics
IOVA
$901M
| $689K | ﹤0.01% |
23,000
-22,000
| -49% | -$659K |
|
|
IMMU
344
DELISTED
Immunomedics Inc
IMMU
| $674K | ﹤0.01% |
50,000
+4,000
| +9% | +$53.9K |
|
345
Neurocrine Biosciences
NBIX
$14.3B
| $673K | ﹤0.01% |
7,775
-30,550
| -80% | -$2.64M |
|
346
FibroGen
FGEN
$48.9M
| $626K | ﹤0.01% |
720
-200
| -22% | -$174K |
|
347
Chewy
CHWY
$17.5B
| $622K | ﹤0.01% |
+16,594
| New | +$622K |
|
348
Fate Therapeutics
FATE
$116M
| $622K | ﹤0.01% |
28,000
-20,000
| -42% | -$444K |
|
349
Mesa Laboratories
MLAB
$356M
| $609K | ﹤0.01% |
2,694
+1,029
| +62% | +$233K |
|
350
Prologis
PLD
$105B
| $587K | ﹤0.01% |
7,305
| – | – |
|